Bisphosphonate use and breast cancer recurrence risk in the QUILT cohort

被引：0
|
作者：
Korde, L. A.
Doody, D. R.
Malone, K. E.
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-15-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-15-03
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Bisphosphonate use following first primary ER plus breast cancer and risk of second primary breast cancer
    Monsees, Genevieve M.
    Newcomb, Polly
    Malone, Kathi
    Li, Christopher
    CANCER RESEARCH, 2011, 71
  • [22] Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort
    Nickels, Stefan
    Vrieling, Alina
    Seibold, Petra
    Heinz, Judith
    Obi, Nadia
    Flesch-Janys, Dieter
    Chang-Claude, Jenny
    PLOS ONE, 2013, 8 (09):
  • [23] Risk of renal failure associated with IV bisphosphonate use in patients with metastatic breast cancer
    Langeberg, W. J.
    Chung, K.
    Lage, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] No increased GI cancer risk with bisphosphonate use
    Reactions Weekly, 2013, 1439 (1) : 2 - 2
  • [25] Bisphosphonate Use and Risk of Colorectal Cancer Reply
    Singh, Siddharth
    Singh, Abha G.
    Murad, Mohammad Hassan
    Limburg, Paul J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (09) : 1209 - 1210
  • [26] Breast cancer recurrence risk in relation to antidepressant use after diagnosis
    Jessica Chubak
    Diana S. M. Buist
    Denise M. Boudreau
    Mary Anne Rossing
    Thomas Lumley
    Noel S. Weiss
    Breast Cancer Research and Treatment, 2008, 112 : 123 - 132
  • [27] Breast cancer recurrence risk in relation to antidepressant use after diagnosis
    Chubak, Jessica
    Buist, Diana S. M.
    Boudreau, Denise M.
    Rossing, Mary Anne
    Lumley, Thomas
    Weiss, Noel S.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (01) : 123 - 132
  • [28] Perspectives on the future of bisphosphonate use in breast cancer patients
    Clemons, M
    Rea, D
    SEMINARS IN ONCOLOGY, 2004, 31 (05) : 87 - 91
  • [29] Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients
    Kyrgidis, Athanassios
    Triaridis, Stefanos
    Vahtsevanos, Kostantinos
    Antoniades, Kostantinos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (08) : 1125 - 1134
  • [30] Statins and risk of breast cancer recurrence
    Sakellakis, Minas
    Akinosoglou, Karolina
    Kostaki, Anastasia
    Spyropoulou, Despina
    Koutras, Angelos
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 199 - 205
12345